Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma

Clinical Cancer Research

Volumn 9, Issue 6, 2003, Pages 2151-2156

  Zhang, Zun Wu ^a   Newcomb, Paul ^a   Hollowood, Andrew ^a   Feakins, Roger ^d   Moorghen, Moganaden ^a   Storey, Alan ^b   Farthing, Michael J G ^c   Alderson, Derek ^a   Holly, Jeff ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; PROTEIN P53;

AGED; AGING; ARTICLE; CANCER RISK; CARDIA; CODON; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; ARGININE; CARDIA; CODON; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037501107     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Fan, R., Wu, M. T., Miller, D., Wain, J. C., Kelsey, K. T., Wiencke, J. K., and Christiani, D. C. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 9: 1037-1042, 2000.
2. Birgander, R., Sjalander, A., Zhou, Z., Fan, C., Beckman, L., and Beckman, G. p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum. Hered., 46: 49-54, 2001.
3. Birgander, R., Sjalander, A., Rannug, A., Alexandrie, A. K., Sundberg, M. I., Seidegard, J., Tornling, G., Beckman, G., and Beckman, L. p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis (Lond.), 16: 2233-2236, 1995.
4. Murata, M., Tagawa, M., Kimura, M., Kimura, H., Watanabe, S., and Saisho, H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis (Lond.), 17: 261-264, 1996.
5. Sjalander, A., Birgander, R., Hallmans, G., Cajander, S., Lenner, P., Athlin, L., Beckman, G., and Beckman, L. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis (Lond.), 17: 1313-1316, 1996.
6. Wang, Y. C., Lee, H. S., Chen, S. K., Chang, Y. Y., and Chen, C. Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur. J. Cancer, 35: 226-230, 1999.
7. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., and Georgiev, G. P. A variation in the structure of the protein-coding region of the human p53 gene. Gene, 70: 245-252, 1988.
8. Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., and Crawford, L. V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7: 961-963, 1987.
9. Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L., and Matlashewski, G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol., 19: 1092-1100, 1999.
10. Jin, X., Wu, X., Roth, J. A., Amos, C. I., King, T. M., Branch, C., Honn, S. E., and Spitz, M. R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (Lond.), 16: 2205-2208, 1995.
11. Wang, Y. C., Chen, C. Y., Chen, S. K., Chang, Y. Y., and Lin, P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin. Cancer Res., 5: 129-134, 1999.
12. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis (Lond.), 14: 1085-1089, 1993.
13. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., and Banks, L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (Lond.), 393: 229-234, 1998.
14. Tenti, P., Vesentini, N., Rondo-Spaudo, M., Zappatore, R., Migliora, P., Carnevali, L., and Ranzani, G. N. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol. Biomark. Prev., 9: 435-438, 2000.
15. Devesa, S. S., and Fraumeni, J. F. The rising incidence of gastric cardia cancer. J. Natl. Cancer Inst. (Bethesda), 91: 747-749, 1999.
16. Devesa, S. S., Blot, W. J., and Fraumeni, J. F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (Phila.), 83: 2049-2053, 1998.
17. Whelan, S. L., Parkin, D. M., and Masuyer, E. (eds.). Trends in cancer incidence and mortality. Lyon, France: IARC Scientific Publications, 1993.
18. American Cancer Society. Cancer facts and figures, 1995. Atlanta: American Cancer Society, 1995.
19. Stadtlander, C. T., and Waterbor, J. W. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis (Lond.), 20: 2195-2208, 1999.
20. Hotz, J., and Goebell, H. Epidemiology and pathogenesis of gastric carcinoma. In: H. J. Meyer and H. J. Schmoll (eds.), Gastric Carcinoma, pp. 3-15. New York: Springer-Verlag, 1989.
21. Tahara, E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol., 119: 265-272, 1993.
22. Zhang, Z. W., and Farthing, M. J. G. Molecular mechanisms of H pylori associated gastric carcinogenesis. World J. Gastroenterol., 5: 369-374, 1999.
23. Shepherd, T., Tolbert, D., Benedetti, J., Macdonald, J., Stemmermann, G., Wiest, J., DeVoe, G., Miller, M. A., Wang, J., Noffsinger, A., and Fenoglio-Preiser, C. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology, 118: 1039-1044, 2000.
24. Percy, C., Van Holten, V., and Muir, C. (eds.). International classification of diseases for oncology, Ed. 2. Geneva: World Health Organization, 1990.
25. Shiao, Y. H., Palli, D., Caporaso, N. E., Alvord, W. G., Amorosi, A., Nesi, G., Saieva, C., Masala, G., Fraumeni, J. F., and Rice, J. M. Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers. Cancer Epidemiol. Biomark. Prev., 9: 631-633, 2000.
26. Bonafe, M., Olivieri, F., Mari, D., Baggio, G., Mattace, R., Berardelli, M., Sansoni, P., De-Benedictis, G., De-Luca, M., Marchegiani, F., Cavallone, L., Cardelli, M., Giovagnetti, S., Ferrucci, L., Amadio, L., Lisa, R., Tucci, M. G., Troiano, L., Pini, G., Gueresi, P., Morellini, M., Sorbi, S., Passeri, G., Barbi, C., and Valensin, S. p53 codon 72 polymorphism and longevity: additional data on centenarians from continental Italy and Sardinia. Am. J. Hum. Genet., 65: 1782-1785, 1999.
27. Murata, M., Tagawa, M., Kimura, H., Kakisawa, K., Shirasawa, H., and Fujisawa, T. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Int. J. Oncol., 12: 577-581, 1998.
28. Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., Vousden, K. H., Allday, M. J., Gusterson, B., Ikawa, S., Hinds, P. W., Crook, T., and Kaelin, W. G. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet., 25: 47-54, 2000.
29. Kawaguchi, H., Ohno, S., Araki, K., Miyazaki, M., Saeki, H., Watanabe, M., Tanaka, S., and Sugimachi, K. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res., 60: 2753-2755, 2000.
30. Everett, S. M., and Axon, A. T. Early gastric cancer in Europe. Gut, 41: 142-150, 1997.
31. Leocata, P., Gallo, P., Chiominto, A., Saltarelli, S., Cioccocioppo, R., Saltarelli, P., Di-Giacomo, C., and Ventura, L. Is early gastric cancer, diffuse type, a forerunner of advanced gastric cancer? Tumori, 79: 108-111, 1993.
32. Eckardt, V. F., Giessler, W., Kanzler, G., Remmele, W., and Bernhard, G. Clinical and morphological characteristics of early gastric cancer. A case-control study. Gastroenterology, 98: 708-714, 1990.
33. Berrino, F., Sant, M., Verdecchia, A., Capocaccia, R., Hakulinen, T., and Esteve, J. Survival of Cancer Patients in Europe - the EUROCARE Study, IARC Sci. Publ. No. 132. Lyon, France: IARC, 1995.
34. Ries, L. A. G, Kosary, C. L., Hankey, B. F., Miller, B. A., and Edwards, B. K. SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute, 1999.
35. Raffle, A. E., Alden, B., and Mackenzie, E. F. Detection rates for abnormal cervical smears: what are we screening for? Lancet, 345: 1469-1473, 1995.
36. Schmidt, J. G. The epidemiology of mass breast cancer screening-a plea for a valid measure of benefit. J. Clin. Epidemiol., 43: 215-225, 1990.
37. Axon, A. Natural history of early gastric cancer. Gut, 47: 609, 2000.